Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis.

Fujiwara Y, Okamura Y, Ramesh M, Tehrani YF, Aburaki R, Takahashi T, Ahluwalia MS, Mukherjee S

Open source

DOI
10.1093/jncics/pkag066
Published
2026 Jul 7
Container
JNCI cancer spectrum
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jncics/pkag066,
  title = {Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis.},
  author = {Fujiwara Y and Okamura Y and Ramesh M and Tehrani YF and Aburaki R and Takahashi T and Ahluwalia MS and Mukherjee S},
  year = {2026},
  journal = {JNCI cancer spectrum},
  doi = {10.1093/jncics/pkag066},
  url = {https://doi.org/10.1093/jncics/pkag066}
}

RIS

TY  - JOUR
TI  - Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis.
AU  - Fujiwara Y
AU  - Okamura Y
AU  - Ramesh M
AU  - Tehrani YF
AU  - Aburaki R
AU  - Takahashi T
AU  - Ahluwalia MS
AU  - Mukherjee S
PY  - 2026
JO  - JNCI cancer spectrum
DO  - 10.1093/jncics/pkag066
UR  - https://doi.org/10.1093/jncics/pkag066
ER  - 

APA

Y, F., Y, O., M, R., YF, T., R, A., T, T., MS, A., & S, M. (2026). Safety of immune checkpoint modulators beyond PD-1/PD-L1 and CTLA-4 in solid tumors: a meta-analysis.. JNCI cancer spectrum. https://doi.org/10.1093/jncics/pkag066

Source records